{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T23:16:04Z","timestamp":1783206964009,"version":"3.54.6"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["HEA663300003"],"award-info":[{"award-number":["HEA663300003"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijbiomac.2026.152709","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T15:04:54Z","timestamp":1779721494000},"page":"152709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Chitosan-coated cyclodextrin-based niosomes enable enhanced nose-to-brain delivery of rivastigmine and asiaticoside for Alzheimer's disease"],"prefix":"10.1016","volume":"369","author":[{"given":"Hay Marn","family":"Hnin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theingi","family":"Tun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanchai","family":"Chongcharoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nonthaneth","family":"Nalinratana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratchanee","family":"Rodsiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsteinn","family":"Loftsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harendra S.","family":"Parekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phatsawee","family":"Jansook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152709_bb0005","doi-asserted-by":"crossref","first-page":"445","DOI":"10.31887\/DCNS.2013.15.4\/hjahn","article-title":"Memory loss in Alzheimer\u2019s disease","volume":"15","author":"Jahn","year":"2022","journal-title":"Dialogues Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152709_bb0010","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06181.x","article-title":"The amyloid hypothesis for Alzheimer\u2019s disease: a critical reappraisal","volume":"110","author":"Hardy","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0015","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s10072-019-03863-x","article-title":"On the central role of mitochondria dysfunction and oxidative stress in Alzheimer\u2019s disease","volume":"40","author":"Tobore","year":"2019","journal-title":"Neurol. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152709_bb0020","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.neuint.2012.08.014","article-title":"Metal dyshomeostasis and oxidative stress in Alzheimer\u2019s disease","volume":"62","author":"Greenough","year":"2013","journal-title":"Neurochem. Int."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152709_bb0025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1368-5031.2005.00769.x","article-title":"Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer\u2019s disease who failed to benefit from previous cholinesterase inhibitor treatment","volume":"60","author":"Dantoine","year":"2006","journal-title":"Int. J. Clin. Pract."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152709_bb0030","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1517\/14740338.2014.914168","article-title":"Outcomes of Alzheimer\u2019s disease therapy with acetylcholinesterase inhibitors and memantine","volume":"13","author":"Zemek","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152709_bb0035","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3390\/biomedicines10071510","article-title":"Novel rivastigmine derivatives as promising multi-target compounds for potential treatment of Alzheimer\u2019s disease","volume":"10","author":"Vicente-Zurdo","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2021.02.015","article-title":"Design, development and in-vitro\/in-vivo evaluation of intranasally delivered Rivastigmine and N-acetyl cysteine loaded bifunctional niosomes for applications in combinative treatment of Alzheimer\u2019s disease","volume":"163","author":"Kulkarni","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"25","key":"10.1016\/j.ijbiomac.2026.152709_bb0045","doi-asserted-by":"crossref","first-page":"13757","DOI":"10.1039\/D0NR04037A","article-title":"Bi-functional sterically hindered phenol lipid-based delivery systems as potential multi-target agents against Alzheimer's disease via an intranasal route","volume":"12","author":"Burilova","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0050","series-title":"Seminars in Neurology","first-page":"227","article-title":"Current and future treatments in Alzheimer's disease","author":"Atri","year":"2019"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152709_bb0055","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1254\/jphs.12166SC","article-title":"Synergistic effects of galantamine and memantine in attenuating scopolamine-induced amnesia in mice","volume":"120","author":"Busquet","year":"2012","journal-title":"J. Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.152709_bb0060","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1586\/ern.12.124","article-title":"Rationale for combining glutamatergic and cholinergic approaches in the symptomatic treatment of Alzheimer\u2019s disease","volume":"12","author":"Francis","year":"2012","journal-title":"Expert. Rev. Neurother."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152709_bb0065","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3122\/jabfm.2012.03.100183","article-title":"Guidelines for the management of cognitive and behavioral problems in dementia","volume":"25","author":"Sadowsky","year":"2012","journal-title":"J. Am. Board Fam. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152709_bb0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejps.2012.04.013","article-title":"Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting","volume":"47","author":"Fazil","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.152709_bb0075","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.12980\/jclm.4.2016J6-161","article-title":"A review on phytopharmaceutical importance of asiaticoside","volume":"4","author":"Patel","year":"2016","journal-title":"J Coast Life Med"},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0080","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.biopha.2018.05.156","article-title":"Comparison of three different extracts of Centella asiatica for anti-amnesic, antioxidant and anticholinergic activities: in vitro and in vivo study","volume":"105","author":"Arora","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152709_bb0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1097-4547(19991101)58:3<417::AID-JNR7>3.0.CO;2-G","article-title":"Protective effects of asiaticoside derivatives against beta-amyloid neurotoxicity","volume":"58","author":"Mook-Jung","year":"1999","journal-title":"J. Neurosci. Res."},{"issue":"15","key":"10.1016\/j.ijbiomac.2026.152709_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25153353","article-title":"Combining in silico and in vitro studies to evaluate the acetylcholinesterase inhibitory profile of different accessions and the biomarker triterpenes of Centella asiatica","volume":"25","author":"Jusril","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152709_bb0095","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.carbpol.2011.02.023","article-title":"Use of 2-hydroxypropyl-\u03b2-cyclodextrin as adjuvant for enhancing encapsulation and release characteristics of asiaticoside within and from cellulose acetate films","volume":"85","author":"Panichpakdee","year":"2011","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152709_bb0100","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2017.11.018","article-title":"Cyclodextrins: structure, physicochemical properties and pharmaceutical applications","volume":"535","author":"Jansook","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0105","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ijbiomac.2022.06.031","article-title":"Preparation and evaluation of niosomal chitosan-based in situ gel formulation for direct nose-to-brain methotrexate delivery","volume":"213","author":"Ourani-Pourdashti","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0110","article-title":"Niosomes for nose-to-brain delivery of bromocriptine: formulation development, efficacy evaluation and toxicity profiling","volume":"58","author":"Sita","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119181","article-title":"Advantages of the combined use of cyclodextrins and nanocarriers in drug delivery: a review","volume":"579","author":"Mura","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152709_bb0120","article-title":"A comprehensive review on cyclodextrin-based carriers for delivery of chemotherapeutic cytotoxic anticancer drugs","volume":"2015","author":"Gidwani","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152709_bb0125","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4103\/0110-5558.76436","article-title":"Mucoadhesive drug delivery system: an overview","volume":"1","author":"Boddupalli","year":"2010","journal-title":"J. Adv. Pharm. Technol. Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152709_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/membranes10090212","article-title":"A reevaluation of chitosan-decorated nanoparticles to cross the blood-brain barrier","volume":"10","author":"Cort\u00e9s","year":"2020","journal-title":"Membranes"},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0135","first-page":"113","article-title":"Formation and stability of inorganic complexes in solution","volume":"9","author":"Job","year":"1928","journal-title":"Ann. Chim."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152709_bb0140","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1208\/pt070104","article-title":"Determination of aqueous solubility by heating and equilibration: a technical note","volume":"7","author":"Loftsson","year":"2006","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124170","article-title":"Development and validation of high-performance liquid chromatography method for the simultaneous quantification of rivastigmine hydrogen tartrate and asiaticoside co-loaded in niosomes: A Box\u2013Behnken design approach","volume":"1241","author":"Hnin","year":"2024","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0150","first-page":"117","article-title":"A phase solubility technique","volume":"4","author":"Higuchi","year":"1965","journal-title":"Adv. Anal. Chem. Instrum."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152709_bb0155","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/08982104.2016.1191022","article-title":"Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation","volume":"27","author":"Khalil","year":"2017","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2021.102341","article-title":"Development and optimization of chitosan coated nanoemulgel of telmisartan for intranasal delivery: a comparative study","volume":"62","author":"Chin","year":"2021","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0165","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ijbiomac.2016.09.027","article-title":"Composite chitosan-transfersomal vesicles for improved transnasal permeation and bioavailability of verapamil","volume":"93","author":"Mouez","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0170","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejps.2016.05.008","article-title":"Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: formulation, physicochemical and pharmacokinetic consideration","volume":"91","author":"Shah","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152709_bb0175","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/j.xphs.2021.04.020","article-title":"Novel chitosan-coated niosomal formulation for improved management of bacterial conjunctivitis: a highly permeable and efficient ocular nanocarrier for azithromycin","volume":"110","author":"Eid","year":"2021","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152709_bb0180","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2004.10.026","article-title":"Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system","volume":"290","author":"Aggarwal","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152709_bb0185","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejps.2012.12.007","article-title":"Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model","volume":"48","author":"Md","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152709_bb0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2012.04.060","article-title":"Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studies","volume":"432","author":"Bhatta","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0195","series-title":"Strategies to Modify the Drug Release from Pharmaceutical Systems","author":"Bruschi","year":"2015"},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.103174","article-title":"Cyclodextrin-based Pickering nanoemulsions containing amphotericin B: part II. Formulation, antifungal activity, and chemical stability","volume":"69","author":"Maw","year":"2022","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152709_bb0205","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.xphs.2019.03.020","article-title":"Application of Box-Behnken design in the preparation, optimization, and in vitro evaluation of self-assembly\u2013based tamoxifen- and doxorubicin-loaded and dual drug\u2013loaded niosomes for combinatorial breast cancer treatment","volume":"108","author":"Kulkarni","year":"2019","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152709_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2016.09.086","article-title":"Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs","volume":"515","author":"Gon\u00e7alves","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152709_bb0215","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s13346-022-01245-z","article-title":"Transferrin-modified chitosan nanoparticles for targeted nose-to-brain delivery of proteins","volume":"13","author":"Gabold","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"issue":"46","key":"10.1016\/j.ijbiomac.2026.152709_bb0220","doi-asserted-by":"crossref","first-page":"11998","DOI":"10.1002\/anie.201304157","article-title":"Method of continuous variations: applications of job plots to the study of molecular associations in organometallic chemistry","volume":"52","author":"Renny","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152709_bb0225","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1080\/14756366.2020.1869225","article-title":"Solubility enhancement of mefenamic acid by inclusion complex with \u03b2-cyclodextrin: in silico modelling, formulation, characterisation, and in vitro studies","volume":"36","author":"Sid","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152709_bb0230","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/jps.23077","article-title":"Cyclodextrins as functional excipients: methods to enhance complexation efficiency","volume":"101","author":"Loftsson","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0235","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jpba.2014.02.022","article-title":"Analytical techniques for characterization of cyclodextrin complexes in aqueous solution: a review","volume":"101","author":"Mura","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152709_bb0240","doi-asserted-by":"crossref","first-page":"20","DOI":"10.15171\/apb.2020.003","article-title":"Formulation and evaluation of eudragit RL-100 nanoparticles loaded in-situ forming gel for intranasal delivery of rivastigmine","volume":"10","author":"Salatin","year":"2020","journal-title":"Adv Pharm Bull"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152709_bb0245","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7317\/pk.2014.38.3.338","article-title":"Electrospinning of asiaticoside\/2-hydroxypropyl-\u03b2-cyclodextrin inclusion complex-loaded cellulose acetate fiber mats: release characteristics and potential for use as wound dressing","volume":"38","author":"Panichpakdee","year":"2014","journal-title":"Polym Korea"},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2020.108190","article-title":"The investigation of binary and ternary sulfobutylether-\u03b2-cyclodextrin inclusion complexes with asiaticoside in solution and in solid state","volume":"498","author":"Soe","year":"2020","journal-title":"Carbohydr. Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152709_bb0255","article-title":"Inclusion complexes of \u03b2 and HP\u03b2-cyclodextrin with \u03b1, \u03b2 amyrin and in vitro anti-inflammatory activity","volume":"9","author":"da Silva","year":"2019","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152709_bb0260","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1208\/s12249-023-02684-8","article-title":"ApoE3 anchored liposomal delivery of rivastigmine for brain delivery: formulation, characterization, and in vivo pharmacokinetic evaluation","volume":"24","author":"Khairnar","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123418","article-title":"Valine conjugated polymeric nanocarriers for targeted co-delivery of rivastigmine and quercetin in rat model of Alzheimer disease","volume":"645","author":"Kaboli","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2016.09.005","article-title":"Porous microspheres as promising vehicles for the topical delivery of poorly soluble asiaticoside accelerate wound healing and inhibit scar formation in vitro & in vivo","volume":"109","author":"Zhang","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0275","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejps.2015.08.001","article-title":"Influence of hydrophilic polymers on the complexation of carbamazepine with hydroxypropyl-\u03b2-cyclodextrin","volume":"78","author":"Medarevi\u0107","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152709_bb0280","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3746\/pnf.2020.25.4.440","article-title":"Synthesis and characterization of phenolic acid\/hydroxypropyl-\u03b2-cyclodextrin inclusion complexes","volume":"25","author":"Kim","year":"2020","journal-title":"Prev Nutr Food Sci"},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0285","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejps.2016.05.012","article-title":"Intranasal delivery of nanoparticle encapsulated tarenflurbil: a potential brain targeting strategy for Alzheimer\u2019s disease","volume":"92","author":"Muntimadugu","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152709_bb0290","first-page":"323","article-title":"Formulation and evaluation of niosomes","volume":"73","author":"Okore","year":"2011","journal-title":"Indian J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152709_bb0295","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.2174\/1567201815666180619105419","article-title":"Implementing central composite design for developing transdermal diacerein-loaded niosomes: ex vivo permeation and in vivo deposition","volume":"15","author":"Aziz","year":"2018","journal-title":"Curr. Drug Deliv."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152709_bb0300","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/nano9020145","article-title":"Fabrication and evaluation of lambda-cyhalothrin nanosuspension by one-step melt emulsification technique","volume":"9","author":"Wang","year":"2019","journal-title":"Nanomaterials"},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152709_bb0305","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1080\/03639045.2017.1310224","article-title":"Enhanced oral bioavailability and sustained delivery of glimepiride via niosomal encapsulation: in-vitro characterization and in-vivo evaluation","volume":"43","author":"Mohsen","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152709_bb0310","first-page":"322","article-title":"Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: in-vitro and ex-vivo investigations","volume":"10","author":"Zubairu","year":"2015","journal-title":"Asian J Pharm Sci"},{"issue":"52","key":"10.1016\/j.ijbiomac.2026.152709_bb0315","doi-asserted-by":"crossref","first-page":"29909","DOI":"10.1039\/C8RA05021J","article-title":"Cyclodextrin modified niosomes to encapsulate hydrophilic compounds","volume":"8","author":"Machado","year":"2018","journal-title":"RSC Adv."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152709_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/ph15070816","article-title":"Targeting colorectal cancer cells with niosomes systems loaded with two anticancer drugs models; comparative in vitro and anticancer studies","volume":"15","author":"El-Far","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152709_bb0325","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/pharmaceutics14030588","article-title":"Strategies to improve drug strength in nasal preparations for brain delivery of low aqueous solubility drugs","volume":"14","author":"Pires","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152709_bb0330","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/10717544.2013.849778","article-title":"Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation","volume":"21","author":"Galgatte","year":"2014","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152709_bb0335","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202000076","article-title":"Polymeric nanoparticles for nasal drug delivery to the brain: relevance to Alzheimer's disease","volume":"4","author":"Rabiee","year":"2021","journal-title":"Adv Therap"},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0340","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1208\/s12249-017-0780-7","article-title":"Optimized mucoadhesive coated niosomes as a sustained oral delivery system of famotidine","volume":"18","author":"Khalifa","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0345","article-title":"Chitosan coated niosomes for nose-to-brain delivery of clonazepam: formulation, stability and permeability studies","volume":"6","author":"Nerli","year":"2023","journal-title":"Carbohydr. Polym. Technol. Appl."},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0350","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijbiomac.2016.04.076","article-title":"Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route","volume":"89","author":"Shah","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152709_bb0355","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1021\/bm800276d","article-title":"Why is chitosan mucoadhesive?","volume":"9","author":"Sogias","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0360","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.carbpol.2018.07.054","article-title":"Box-Behnken design optimization of mucoadhesive chitosan-coated nanoemulsions for rosmarinic acid nasal delivery\u2014in vitro studies","volume":"199","author":"Fachel","year":"2018","journal-title":"Carbohydr. Polym."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2026.152709_bb0365","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijpharm.2012.04.007","article-title":"Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome","volume":"430","author":"Qiang","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0370","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.carbpol.2015.04.048","article-title":"Liposomes incorporating cyclodextrin\u2013drug inclusion complexes: current state of knowledge","volume":"129","author":"Gharib","year":"2015","journal-title":"Carbohydr. Polym."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.152709_bb0375","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1208\/s12249-011-9675-1","article-title":"Brimonidine tartrate\u2013eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation","volume":"12","author":"Bhagav","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2023.122749","article-title":"Riluzole-loaded lipid nanoparticles for brain delivery: preparation, optimization and characterization","volume":"388","author":"In\u00eas Teixeira","year":"2023","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0385","article-title":"Novel nasal niosomes loaded with lacosamide and coated with chitosan: a possible pathway to target the brain to control partial-onset seizures","volume":"6","author":"Tulbah","year":"2023","journal-title":"Int J Pharm X"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152709_bb0390","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/jps.20627","article-title":"In vitro hemolysis: guidance for the pharmaceutical scientist","volume":"95","author":"Amin","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119776","article-title":"Chitosan-coated PLGA nanoparticles for the nasal delivery of ropinirole hydrochloride: in vitro and ex vivo evaluation of efficacy and safety","volume":"589","author":"Chatzitaki","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.152709_bb0400","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.3390\/pharmaceutics13101686","article-title":"Chitosan nanoparticles at the biological interface: implications for drug delivery","volume":"13","author":"Aibani","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2026.152709_bb0405","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejps.2016.09.002","article-title":"Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein","volume":"95","author":"Khan","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152709_bb0410","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.3390\/pharmaceutics14091798","article-title":"Quality by design-driven zeta potential optimisation study of liposomes with charge imparting membrane additives","volume":"14","author":"N\u00e9meth","year":"2022","journal-title":"Pharmaceutics"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302602636X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302602636X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T22:22:30Z","timestamp":1783203750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302602636X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":82,"alternative-id":["S014181302602636X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152709","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chitosan-coated cyclodextrin-based niosomes enable enhanced nose-to-brain delivery of rivastigmine and asiaticoside for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152709","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152709"}}